MAR 28, 2020 8:39 AM PDT

The Antibody Test to See if You've Already Had the Coronavirus

WRITTEN BY: Annie Lennon

Knowing whether you’ve had the virus or not may not just reduce your need to panic- but also better help epidemiologists map out the spread of the virus. Now, Henry Schein Inc, the world’s largest distributor of dental and medical supplies, has released an antibody rapid blood test that can tell you if you’ve had the coronavirus before. And it does this in less than 15 minutes. 

Known as Standard Q COVID-19 IgM/IgG Rapid Test, it is a rapid immunochromatography test designed to detect specific IgM and IgG antibodies associated with the novel coronavirus from blood drawn by a pinprick. Detecting the presence of these antibodies, when taken with other information including the presence of symptoms and medical history, the test allows medical professionals to tell whether a person has already been infected by the virus, and whether they may be currently infected by it too. 

Currently available under emergency guidance by the US Food and Drug Administration, Stanley M Bergman, chairman of the Board and CEO of Henry Schein said, “This pandemic is an unprecedented situation, and making rapid diagnostic tools available to health care professionals is critical for detecting and mitigating the spread of the coronavirus.”

Other private companies have also begun selling blood tests capable of detecting coronavirus antibodies. For example, California-based Biomerica sells its tests for less than $10, and has already had orders placed from Europe and the Middle East. Chembio Diagnostics from New York has reportedly received an order for $4 million- worth of antibody tests against the virus, while South Korean test maker, Sugantech, is also reportedly producing tests. 

Meanwhile, researchers are also investigating the viability of antibody tests. Fatima Amanat, a PhD candidate at the Icahn School of Medicine at Mount Sinai, is currently developing tests for first responders and healthcare providers in particular. She said,  “Right now, if you have a highly infectious COVID-19 patient, it's really a problem to send a nurse who is not immune to it already because she’s so susceptible. Our test would be for all the doctors and healthcare providers, to see if they're already immune to it and have antibodies.”



Sources: US Dental Tribune, Vice and Reuters 

About the Author
Other
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
DEC 01, 2022
Genetics & Genomics
No more manual library preps!
No more manual library preps!
BioQuleTM NGS System - Say ‘goodbye’ to manual library prepping and ‘hello’ to generating librar ...
NOV 29, 2022
Drug Discovery & Development
Kicking Pro-tumor Immune Cells Out of the Microenvironment
Kicking Pro-tumor Immune Cells Out of the Microenvironment
Tumors use our own immune systems against us by coaxing regulatory T cells to keep antitumor immune response low. But re ...
NOV 30, 2022
Cannabis Sciences
Losing weight with cannabis
Losing weight with cannabis
Is it possible to lose weight with cannabis? Here's what the latest research tells us.
JAN 31, 2023
Neuroscience
Acoustic Decoding of Brain Waves to Detect the Music a Person Is Hearing
Acoustic Decoding of Brain Waves to Detect the Music a Person Is Hearing
  Researchers at the University of Essex discovered a for monitoring brain waves that can identify the music a pers ...
JAN 30, 2023
Cancer
Kiwi Juice Provides Therapeutic Benefit in Lung Cancer Model
Kiwi Juice Provides Therapeutic Benefit in Lung Cancer Model
Actinidia arguta, commonly known as the hardy kiwi or kiwi berry, looks like a smaller, hairless version of the Actinidi ...
FEB 02, 2023
Drug Discovery & Development
Potential New Vaccine for Deadly Re-Emerging Virus
Potential New Vaccine for Deadly Re-Emerging Virus
This relative of the six Ebola virus species has no known treatment. Now, a new vaccine is showing promise.
Loading Comments...